Skip to main content
Have a personal or library account? Click to login
The Effect of Glaucoma on the Quality of Patient’s Life Cover

The Effect of Glaucoma on the Quality of Patient’s Life

Open Access
|Mar 2021

References

  1. 1. Chun Y, Lee DI, Kwon J, et al. Comparison of impact of monocular and integrated binocular visual fields on vision- related quality of life. J Glaucoma. 2017;26:283–291.10.1097/IJG.000000000000062328079653
  2. 2. van Gestel A, Webers CA, Beckers HJ, et al. The relationship between visual field loss in glaucoma and health-related quality-of-life. Eye (Lond). 2010;24:1759–1769.10.1038/eye.2010.13321057519
  3. 3. Asaoka R, Crabb DP, Yamashita T, et al. Patients have two eyes!: binocular versus better eye visual field indices. Invest Ophthalmol Vis Sci. 2011;52:7007–7011.10.1167/iovs.11-764321810985
  4. 4. Lisboa R, Chun YS, Zangwill LM, et al. Association between rates of binocular visual field loss and vision-related quality of life in patients with glaucoma. JAMA Ophthalmol. 2013;131:486–494.10.1001/jamaophthalmol.2013.2602380426423450425
  5. 5. Cheng HC, Guo CY, Chen MJ, et al. Patient-reported vision- related quality of life differences between superior and inferior hemifield visual field defects in primary open-angle glaucoma. JAMA Ophthalmol. 2015;133:269–275.10.1001/jamaophthalmol.2014.490825429608
  6. 6. Quaranta L, Riva I, Gerardi C, et al. Quality of life in glaucoma: a review of the literature. Adv Ther. 2016;33:959–981.10.1007/s12325-016-0333-6492085127138604
  7. 7. Murata H, Hirasawa H, Aoyama Y, et al. Identifying areas of the visual field important for quality of life in patients with glaucoma. PLoS One. 2013;8:e58695.10.1371/journal.pone.0058695359281423520528
  8. 8. Kwon M, Huisingh C, Rhodes LA, et al. Association between glaucoma and at-fault motor vehicle collision involvement among older drivers: a population-based study. Ophthalmology. 2016;123:109–116.10.1016/j.ophtha.2015.08.043469530326459997
  9. 9. Diniz-Filho A, Boer ER, Elhosseiny A, et al. Glaucoma and driving risk under simulated fog conditions. Transl Vis Sci Technol. 2016;5:15.10.1167/tvst.5.6.15515644527980878
  10. 10. Kubler TC, Kasneci E, Rosenstiel W, et al. Driving with glaucoma: task performance and gaze movements. Optom Vis Sci. 2015;92:1037–1046.10.1097/OPX.000000000000070226501733
  11. 11. van Landingham SW, Hochberg C, Massof RW, et al. Driving patterns in older adults with glaucoma. BMC Ophthalmol. 2013;13:4.10.1186/1471-2415-13-4
  12. 12. Nguyen AM, van Landingham SW, Massof RW, et al. Reading ability and reading engagement in older adults with glaucoma. Invest Ophthalmol Vis Sci. 2014;55:5284–’35290.10.1167/iovs.14-14138
  13. 13. Yang Y, Trope GE, Buys YM, et al. Glaucoma severity and participation in diverse social roles: does visual field loss matter? J Glaucoma. 2016;25:e697–e703.10.1097/IJG.0000000000000353
  14. 14. Janz NK,Wren PA, Lichter PR, et al. Quality of life in newly diagnosed glaucoma patients: the Collaborative Initial Glaucoma Treatment Study. Ophthalmology. 2001;108:887–897 discussion 898.10.1016/S0161-6420(00)00624-2
  15. 15. Ramli N, Supramaniam G, Samsudin A, et al. Ocular surface disease in glaucoma: effect of polypharmacy and preservatives. Optom Vis Sci. 2015;92:e222–e226.10.1097/OPX.000000000000054225730335
  16. 16. Pouyeh B, Viteri E, FeuerW, et al. Impact of ocular surface symptoms on quality of life in a United States veterans affairs population. Am J Ophthalmol. 2012;153:1061–1066. e3.10.1016/j.ajo.2011.11.03022330309
  17. 17. Rossi GC, Tinelli C, Pasinetti GM, et al. Dry eye syndrome- related quality of life in glaucoma patients. Eur J Ophthalmol. 2009;19:572–579.10.1177/11206721090190040919551671
  18. 18. Cvenkel B, Stunf S, Srebotnik K, et al. Symptoms and signs of ocular surface disease related to topical medication in patients with glaucoma. Clin Ophthalmol. 2015;9: 625–631.10.2147/OPTH.S81247439951825914521
  19. 19. Perez-Bartolome F, Martinez-de-la-Casa JM, Arriola- Villalobos P, et al. Ocular surface disease in patients under topical treatment for glaucoma. Eur J Ophthalmol. 2017;27: 694–704.10.5301/ejo.500097728497458
  20. 20. Terai N, Muller-Holz M, Spoerl E, et al. Short-term effect of topical antiglaucoma medication on tear-film stability, tear secretion, and corneal sensitivity in healthy subjects. Clin Ophthalmol. 2011;5:517–525.10.2147/OPTH.S18849309030821573041
  21. 21. Anwar Z, Wellik SR, Galor A. Glaucoma therapy and ocular surface disease: current literature and recommendations. Curr Opin Ophthalmol. 2013;24:136–143.10.1097/ICU.0b013e32835c8aba
  22. 22. Tsai JC. A comprehensive perspective on patient adherence to topical glaucoma therapy. Ophthalmology. 2009;116 (suppl):S30–S36.10.1016/j.ophtha.2009.06.024
  23. 23. Janz NK, Wren PA, Lichter PR, et al. The Collaborative Initial Glaucoma Treatment Study: interim quality of life findings after initial medical or surgical treatment of glaucoma. Ophthalmology. 2001;108:1954–1965.10.1016/S0161-6420(01)00874-0
  24. 24. J Ophthalmol. 2017:1–7. King AJ, Fernie G, Azuara- Blanco A, et al. Treatment of Advanced Glaucoma Study: a multicentre randomised controlled trial comparing primary medical treatment with primary trabeculectomy for people with newly diagnosed advanced glaucoma-study protocol. Br.
  25. 25. Zimmerman T, Karunaratne N, Fechtner R. Glaucoma: outcomeology (part I, II). J Glaucoma. 1996;5:151–155.10.1097/00061198-199606000-00001
  26. 26. Spaeth G, Walt J, Keener J. Evaluation of quality of life for patients with glaucoma. Am J Ophthalmol. 2006;141 (suppl):S3–S14.10.1016/j.ajo.2005.07.075
  27. 27. Wilson MR, Coleman AL, Yu F, et al. Functional status and well-being in patients with glaucoma as measured by the Medical Outcomes Study Short Form-36 questionnaire. Ophthalmology. 1998;105:2112–2116.10.1016/S0161-6420(98)91135-6
  28. 28. Aspinall PA, Johnson ZK, Azuara-Blanco A, et al. Evaluation of quality of life and priorities of patients with glaucoma. Invest Ophthalmol Vis Sci. 2008;49:1907–1915.10.1167/iovs.07-055918436824
  29. 29. Khanna CL, Leske DA, Holmes JM. Factors associated with health-related quality of life in medically and surgically treated patients with glaucoma. JAMA Ophthalmol. 2018.10.1001/jamaophthalmol.2018.0012587684729470573
  30. 30. Nutheti R, Shmanna BR, Nirmalan PK, et al. Impact of impaired vision and eye disease on quality of life in Andhra Pradesh. Invest Ophthalmol Vis Sci. 2006;47: 4742–4748.10.1167/iovs.06-002017065482
  31. 31. Peters D, Heijl A, Brenner L, et al. Visual impairment and vision-related quality of life in the Early Manifest Glaucoma Trial after 20 years of follow-up. Acta Ophthalmol. 2015;93:745–752.10.1111/aos.12839501420826382936
  32. 32. Goldberg I, Clement CI, Chiang TH, et al. Assessing quality of life with glaucoma using the Glaucoma Quality of Life-15 (GQL-15) questionairre. J Glaucoma. 2009;18: 6–12.10.1097/IJG.0b013e3181752c8319142128
  33. 33. Day DG, Sharpe Ed, Atkinson MJ, et al. The clinical validity of the treatment satisfaction survey for intraocular pressure in ocular hypertensive and glaucoma patients. Eye (London). 2006;20:583–590.10.1038/sj.eye.670193215933751
  34. 34. Jampel HD, Frick KD, Janz NK, et al. Depression and mood indicators in newly diagnosed glaucoma patients. Am J Ophthalmol. 2007;144:238–244.10.1016/j.ajo.2007.04.04817560843
  35. 35. Mabuchi F, Yoshimura K, Kashiwagi K, et al. High prevalence of anxiety and depression in patients with primary opan-angle glaucoma. J Glaucoma. 2008;17: 552–557.10.1097/IJG.0b013e31816299d418854732
  36. 36. Tastan S, Iyigun E, Bayer A, et al. Anxiety, depression, and quality of life in Turkish patients with glaucoma. Psychol Rep. 2010;106:343–357.10.2466/pr0.106.2.343-357
  37. 37. Zhou C, Qian S, Wu P, et al. Anxiety and depression in Chinese patients with glaucoma: sociodemographic, clinical, and self-reported correlates. J Psychosom Res. 2013;75:72–82.10.1016/j.jpsychores.2013.03.00523751243
  38. 38. Mabuchi F, Yoshimura K, Kashiwagi K, et al. Risk factors for anxiety and depression in patients with glaucoma. Br J Ophthalmol. 2012;96:821–825.10.1136/bjophthalmol-2011-30091022353697
  39. 39. Skalicky S, Goldberg I. Depression and quality of life in patients with glaucoma: a cross-sectional analysis using the Geriatric Depression Scale-15, Assessment of Function Related to Vision, and the Glaucoma Quality of Life-15. J Glaucoma. 2008;17: 546–5.10.1097/IJG.0b013e318163bdd118854731
  40. 40. Stryker JE, Beck AD, Primo SA, et al. An exploratory study of factors influencing glaucoma treatment adherence. J Glaucoma. 2010;19:66–72.10.1097/IJG.0b013e31819c4679280819720075676
  41. 41. Yochim BP, Mueller AE, Kane KD, et al. Prevalence of cognitive impairment, depression, and anxiety symptoms among older adults with glaucoma. J Glaucoma. 2012;21:250–254.10.1097/IJG.0b013e3182071b7e21336151
DOI: https://doi.org/10.2478/sjecr-2020-0046 | Journal eISSN: 2956-2090 (formerly 2335-075X, 2956-0454) | Journal ISSN: 2956-0454 (formerly 1820-8665)
Language: English
Submitted on: Oct 8, 2020
Accepted on: Oct 20, 2020
Published on: Mar 13, 2021
Published by: University of Kragujevac, Faculty of Medical Sciences
In partnership with: Paradigm Publishing Services

© 2021 Elizabeta Marceta, Dusan Todorovic, published by University of Kragujevac, Faculty of Medical Sciences
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.